Monday, December 4, 2017

Pharma Reviews: Indiabulls Pharma receives Rs 155 crore investment from Clermont Group

“At Indiabulls Pharmaceuticals, we want to reshape the Indian pharmaceutical industry landscape by providing next generation therapies to patients at affordable prices. We aspire to be a patient and physician centric, innovative, best-in-class pharmaceutical company,” said Mr. Nikhil Chari, CEO of ...
Read more: Indiabulls Pharma receives Rs 155 crore investment from Clermont Group